ArticleFrontiers in cardiovascular medicine2026
Morphology-based ECG criteria for identifying left-atrial low-voltage areas on voltage mapping: a diagnostic accuracy study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Left atrial (LA) fibrosis contributes to atrial fibrillation (AF) recurrence beyond pulmonary vein triggers, yet its non-invasive identification pre-ablation remains challenging. While invasive voltage mapping may identify low-voltage areas (LVAs) as a surrogate of atrial substrate abnormality, it is impractical for systematic screening. Objective: This single-center retrospective pilot study evaluated the diagnostic performance of predefined ECG morphological criteria for detecting LVAs. Methods: LVAs were used as a surrogate marker for atrial fibrosis and defined as bipolar voltage of <0.50 mV on invasive mapping in sinus rhythm or CS pacing. Four ECG criteria were evaluated: (1) history of atypical atrial flutter, (2) negative atrial vector attenuation in V1, (3) presence of typical or atypical advanced interatrial block (types I-IV), and (4) poor terminal P-wave progression in V4-V6. The presence of at least one of these criteria was considered indicative of LVAs. Diagnostic performance of the ECG criteria was assessed against invasive voltage mapping as the reference standard. Five electrophysiologists independently analyzed 12-lead ECGs (100 mm/s, 40 mm/mV) from 78 patients undergoing first-time AF ablation. Results: LVAs were present in 35 patients. The predefined ECG-based criteria demonstrated sensitivity 85.7% (95% CI: 70.6-93.7), specificity 95.4% (95% CI: 84.5-98.7), positive predictive value 93.8% (95% CI: 79.9-98.3), and negative predictive value 89.1% (95% CI: 77.0-95.3), with an overall diagnostic accuracy of 91.0% (95% CI: 82.6-95.6) and an AUC of 0.905 (95% CI: 0.838-0.972). Interatrial block and poor terminal P-wave progression were the most frequent predictors. Conclusions: This proof-of-concept study demonstrated promising diagnostic performance for morphological ECG-criteria in detecting left-atrial LVAs. The proposed four-criteria model correlated strongly with invasive voltage mapping and may represent a promising candidate for further validation as a non-invasive tool for pre-procedural identification of atrial substrate.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.